UrologyNews.net

Urology Xagena

Search results for "PSA"

A Johns Hopkins study of more than 2,000 men confirms that PSA remains the best measure of the likelihood of cancer recurrence after surgery. Results of the study, published in The Journal of Urol ...


A study showed older men with early stage prostate cancer survive longer if they are treated versus not being treated in favor of the "watchful waiting" approach advocated by many physicians for older ...


The use of Acetylsalicylic acid ( Aspirin ) and other non-steroidal anti-inflammatory drugs ( NSAIDs ) is significantly associated with lower PSA levels, especially among men with prostate cancer, say ...


It is argued that a rapidly rising PSA may indicate a greater risk of diagnosis of prostate cancer even if PSA levels are low. Some guidelines do incorporate PSA velocity cut points as an indication f ...


A comparison of outcomes of different eras of conservative treatment for localized prostate cancer indicates that overall and prostate cancer-specific survival rates are higher for men diagnosed from ...


Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen ( PSA ) are not likely to benefit from further screening and treatment. That is the conclusion of a new study pu ...


Prostate cancer aggressiveness may be established when the tumor is formed and not alter with time, according to a study published in Cancer Research, a journal of the American Association for Cancer ...


Data from the pivotal Phase III ALSYMPCA ( ALpharadin in SYMptomatic Prostate CAncer ) trial of its drug Radium 223 dichloride ( Radium 223 ) in castration-resistant prostate cancer patients with symp ...


The androgen receptor inhibitor, Enzalutamide ( Xtandi ) is approved for the treatment of metastatic castration-resistant prostate cancer that has progressed on Docetaxel. A study has assessed the ac ...


Results from the phase III study of Triptorelin pamoate 11.25 mg ( Decapeptyl 3 months ) administered subcutaneously in patients with locally advanced or metastatic prostate cancer were presented at t ...


Patients with lower urinary tract symptoms ( LUTS ) have a higher prevalence of cardiovascular disease. Researchers have evaluated the correlation between LUTS and cardiovascular risk factors in men p ...


Transurethral resection of the prostate ( TURP ) is considered gold standard for surgical treatment of benign prostatic hyperplasia ( BPH ). In this study, researchers aimed to compare post-operativ ...


Recent guidelines recommend against routine screening for prostate cancer, partly because of the risks associated with overtreatment of clinically indolent tumours. A study aimed to determine the ...


Overdiagnosis and subsequent overtreatment are important side effects of screening for, and early detection of, prostate cancer ( PCa ). Active surveillance ( AS ) is of growing interest as an alterna ...


The results from the STRIVE trial of Enzalutamide ( Xtandi ) compared to Bicalutamide ( Casodex ) in men with castration-resistant prostate cancer ( CRPC ) are published in the Journal of Clinical Onc ...